Metraipolis › archive › dc_012b48eacdcb

Case Report: A case of reversible pulmonary bullae induced by camrelizumab: a new immune-related adverse event — Europe PMC PMID:41098735

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41098735
DOI
10.3389/fimmu.2025.1619702
License (as archived)
solo-consultazione
Archived
2026-11-09T17:05:32.241Z
SHA-256 of the archived text
b98d8af8efc389f237ea89bdca09d28396d51cbcfe544b4799024a6dd5c0e58a
Stable URL of this page
https://metraipolis.com/documento/dc_012b48eacdcb

How to cite

Case Report: A case of reversible pulmonary bullae induced by camrelizumab: a new immune-related adverse event — Europe PMC PMID:41098735 — Europe PMC (en), https://europepmc.org/article/MED/41098735 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_012b48eacdcb (Metraipolis archive dc_012b48eacdcb, sha256 b98d8af8efc389f237ea89bdca09d28396d51cbcfe544b4799024a6dd5c0e58a)
BibTeX
@misc{dc012b48eacdcb,
  title = {Case Report: A case of reversible pulmonary bullae induced by camrelizumab: a new immune-related adverse event — Europe PMC PMID:41098735},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41098735},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_012b48eacdcb; sha256 b98d8af8efc389f237ea89bdca09d28396d51cbcfe544b4799024a6dd5c0e58a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41098735. Agents can read the archived copy with the MCP tool read_document.